OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Design, Synthesis, Characterization, and Crystal Structure Studies of Nrf2 Modulators for Inhibiting Cancer Cell Growth In Vitro and In Vivo
C Prathima, Baburajeev Chumadathil Pookunoth, Venugopal R. Bovilla, et al.
ACS Omega (2021) Vol. 6, Iss. 15, pp. 10054-10071
Open Access | Times Cited: 7
C Prathima, Baburajeev Chumadathil Pookunoth, Venugopal R. Bovilla, et al.
ACS Omega (2021) Vol. 6, Iss. 15, pp. 10054-10071
Open Access | Times Cited: 7
Showing 7 citing articles:
Modulation of NRF2: Biological Dualism in Cancer, Targets and Possible Therapeutic Applications
M. Gallorini, Simone Carradori, Emiliano Panieri, et al.
Antioxidants and Redox Signaling (2023) Vol. 40, Iss. 10-12, pp. 636-662
Closed Access | Times Cited: 16
M. Gallorini, Simone Carradori, Emiliano Panieri, et al.
Antioxidants and Redox Signaling (2023) Vol. 40, Iss. 10-12, pp. 636-662
Closed Access | Times Cited: 16
Variations in the Anticancer Activity of Free and Bound Phenolics of Finger Millet (Eleusine coracana (L) Gaertn; Variety KMR-301) Seeds
Mahadevaswamy G. Kuruburu, Venugopal R. Bovilla, Rimshia Naaz, et al.
Phytomedicine Plus (2022) Vol. 2, Iss. 2, pp. 100276-100276
Open Access | Times Cited: 22
Mahadevaswamy G. Kuruburu, Venugopal R. Bovilla, Rimshia Naaz, et al.
Phytomedicine Plus (2022) Vol. 2, Iss. 2, pp. 100276-100276
Open Access | Times Cited: 22
Phytochemical-rich Fractions from Foxtail Millet (Setaria italica (L.) P. Beauv) Seeds Exhibited Antioxidant Activity and Reduced the Viability of Breast Cancer Cells In Vitro by Inducing DNA Fragmentation and Promoting Cell Cycle Arrest
Mahadevaswamy G. Kuruburu, Venugopal R. Bovilla, Zonunsiami Leihang, et al.
Anti-Cancer Agents in Medicinal Chemistry (2022) Vol. 22, Iss. 13, pp. 2477-2493
Closed Access | Times Cited: 14
Mahadevaswamy G. Kuruburu, Venugopal R. Bovilla, Zonunsiami Leihang, et al.
Anti-Cancer Agents in Medicinal Chemistry (2022) Vol. 22, Iss. 13, pp. 2477-2493
Closed Access | Times Cited: 14
Design and Activity of Novel Oxadiazole Based Compounds That Target Poly(ADP-ribose) Polymerase
Divakar Vishwanath, Swamy Savvemala Girimanchanaika, Dukanya Dukanya, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 703-703
Open Access | Times Cited: 11
Divakar Vishwanath, Swamy Savvemala Girimanchanaika, Dukanya Dukanya, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 703-703
Open Access | Times Cited: 11
Development of targeted therapy of NRF2high esophageal squamous cell carcinoma
Chorlada Paiboonrungruang, Emily J. Simpson, Zhaohui Xiong, et al.
Cellular Signalling (2021) Vol. 86, pp. 110105-110105
Open Access | Times Cited: 11
Chorlada Paiboonrungruang, Emily J. Simpson, Zhaohui Xiong, et al.
Cellular Signalling (2021) Vol. 86, pp. 110105-110105
Open Access | Times Cited: 11
Tetrahydrocarbazoles incorporating 5-arylidene-4-thiazolinones as potential antileukemia and antilymphoma targeting tyrosine kinase and tubulin polymerase enzymes: Design, synthesis, structural, biological and molecular docking studies
Basma S Ali, Anber F. Mohammed, Benson M. Kariuki, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107817-107817
Closed Access | Times Cited: 1
Basma S Ali, Anber F. Mohammed, Benson M. Kariuki, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107817-107817
Closed Access | Times Cited: 1
Anticancer Tetrahydrocarbazoles: A Wide Journey from 2000 Till Date
Nitin Kumar, Pankaj Gupta
Letters in Drug Design & Discovery (2022) Vol. 21, Iss. 3, pp. 421-439
Closed Access | Times Cited: 6
Nitin Kumar, Pankaj Gupta
Letters in Drug Design & Discovery (2022) Vol. 21, Iss. 3, pp. 421-439
Closed Access | Times Cited: 6
